{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:10Z","timestamp":1793726470831,"version":"4.6.1"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Notch signaling is believed to promote cell survival in general. However, the mechanism is not clearly understood. Here, we show that cells expressing intracellular domain of human Notch1 (NIC-1) are chemoresistant in a wild-type p53-dependent manner. NIC-1 inhibited p53 by inhibiting its activating phosphorylations at Ser15, Ser20, and Ser392 as well as nuclear localization. In addition, we found that inhibition of p53 by NIC-1 mainly occurs through mammalian target of rapamycin (mTOR) using phosphatidylinositol 3-kinase (PI3K)-Akt\/protein kinase B (PKB) pathway as the mTOR inhibitor, rapamycin treatment abrogated NIC-1 inhibition of p53 and reversed the chemoresistance. Consistent with this, rapamycin failed to reverse NIC-1-induced chemoresistance in cells expressing rapamycin-resistant mTOR. Further, ectopic expression of eukaryotic initiation factor 4E (eIF4E), a translational regulator that acts downstream of mTOR, inhibited p53-induced apoptosis and conferred protection against p53-mediated cytotoxicity to similar extent as that of NIC-1 overexpression but was not reversed by rapamycin, which indicates that eIF4E is the major target of mTOR in Notch1-mediated survival signaling. Finally, we show that MCF7 (breast cancer) and MOLT4 (T-cell acute lymphoblastic leukemia) cells having aberrant Notch1 signaling are chemoresistant, which can be reversed by both PI3K and mTOR inhibitors. These results establish that Notch1 signaling confers chemoresistance by inhibiting p53 pathway through mTOR-dependent PI3K-Akt\/PKB pathway and imply that p53 status perhaps is an important determinant in combination therapeutic strategies, which use mTOR inhibitors and chemotherapy. (Cancer Res 2006; 66(9): 4715-24)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-3830","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T15:18:51Z","timestamp":1146496731000},"page":"4715-4724","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":202,"title":["Survival Signaling by Notch1: Mammalian Target of Rapamycin (mTOR)\u2013Dependent Inhibition of p53"],"prefix":"10.1158","volume":"66","author":[{"given":"Sathish Kumar","family":"Mungamuri","sequence":"first","affiliation":[{"name":"1Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoHe","family":"Yang","sequence":"additional","affiliation":[{"name":"2Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Thor","sequence":"additional","affiliation":[{"name":"2Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaravel","family":"Somasundaram","sequence":"additional","affiliation":[{"name":"1Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"2022061622291586200_B1","doi-asserted-by":"crossref","unstructured":"Yuan ZQ, Sun M, Feldman RI, et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer. Oncogene\u20082000; 19: 2324\u201330.","DOI":"10.1038\/sj.onc.1203598"},{"key":"2022061622291586200_B2","doi-asserted-by":"crossref","unstructured":"Lasky T, Silbergeld E. p53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers. Environ Health Perspect\u20081996; 104: 1324\u201331.","DOI":"10.1289\/ehp.961041324"},{"key":"2022061622291586200_B3","doi-asserted-by":"crossref","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science\u20081999; 284: 770\u20136.","DOI":"10.1126\/science.284.5415.770"},{"key":"2022061622291586200_B4","doi-asserted-by":"crossref","unstructured":"Weinmaster G. The ins and outs of Notch signaling. Mol Cell Neurosci\u20081997; 9: 91\u2013102.","DOI":"10.1006\/mcne.1997.0612"},{"key":"2022061622291586200_B5","doi-asserted-by":"crossref","unstructured":"Ellisen LW, Bird J, West DC, et al. Tan-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T-lymphoblastic neoplasms. Cell\u20081991; 66: 649\u201361.","DOI":"10.1016\/0092-8674(91)90111-B"},{"key":"2022061622291586200_B6","doi-asserted-by":"crossref","unstructured":"Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. Notch4\/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development (Camb)\u20081996; 122: 2251\u20139.","DOI":"10.1242\/dev.122.7.2251"},{"key":"2022061622291586200_B7","doi-asserted-by":"crossref","unstructured":"Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S, Bishop JM. Neoplastic transformation by truncated alleles of human NOTCH1\/TAN1 and NOTCH2. Mol Cell Biol\u20081997; 17: 6265\u201373.","DOI":"10.1128\/MCB.17.11.6265"},{"key":"2022061622291586200_B8","doi-asserted-by":"crossref","unstructured":"Nair P, Somasundaram K, Krishna S. Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB\/Akt-dependent pathway. J Virol\u20082003; 77: 7106\u201312.","DOI":"10.1128\/JVI.77.12.7106-7112.2003"},{"key":"2022061622291586200_B9","doi-asserted-by":"crossref","unstructured":"Jehn BM, Bielke W, Pear WS, Osborne BA. Cutting Edge: protective effects of notch-1 on TCR-induced apoptosis. J Immunol\u20081999; 162: 635\u20138.","DOI":"10.4049\/jimmunol.162.2.635"},{"key":"2022061622291586200_B10","doi-asserted-by":"crossref","unstructured":"Deftos ML, He YW, Ojala EW, Bevan MJ. Correlating notch signaling with thymocyte maturation. Immunity\u20081998; 9: 777\u201386.","DOI":"10.1016\/S1074-7613(00)80643-3"},{"key":"2022061622291586200_B11","doi-asserted-by":"crossref","unstructured":"Sade H, Krishna S, Sarin A. The anti-apoptotic effect of notch-1 requires p56lck-dependent, Akt\/PKB-mediated signaling in T cells. J Biol Chem\u20082004; 279: 2937\u201344.","DOI":"10.1074\/jbc.M309924200"},{"key":"2022061622291586200_B12","doi-asserted-by":"crossref","unstructured":"Somasundaram K, El-Deiry WS. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300\/CBP-interacting region. Oncogene\u20081997; 14: 1047\u201357.","DOI":"10.1038\/sj.onc.1201002"},{"key":"2022061622291586200_B13","doi-asserted-by":"crossref","unstructured":"Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5\u2032 cap. Nature\u20081990; 345: 544\u20137.","DOI":"10.1038\/345544a0"},{"key":"2022061622291586200_B14","doi-asserted-by":"crossref","unstructured":"Shu L, Zhang X, Houghton PJ. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin. J Biol Chem\u20082002; 277: 16726\u201332.","DOI":"10.1074\/jbc.M112285200"},{"key":"2022061622291586200_B15","doi-asserted-by":"crossref","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A\u20081998; 95: 2509\u201314.","DOI":"10.1073\/pnas.95.5.2509"},{"key":"2022061622291586200_B16","doi-asserted-by":"crossref","unstructured":"Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. Signalling downstream of activated mammalian Notch. Nature\u20081995; 377: 355\u20138.","DOI":"10.1038\/377355a0"},{"key":"2022061622291586200_B17","doi-asserted-by":"crossref","unstructured":"El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell\u20081993; 75: 817\u201325.","DOI":"10.1016\/0092-8674(93)90500-P"},{"key":"2022061622291586200_B18","doi-asserted-by":"crossref","unstructured":"Wajapeyee N, Somasundaram K. Cell cycle arrest and apoptosis induction by activator protein 2\u03b1 (AP-2\u03b1) and the role of p53 and p21WAF1\/CIP1 in AP-2\u03b1-mediated growth inhibition. J Biol Chem\u20082003; 278: 52093\u2013101.","DOI":"10.1074\/jbc.M305624200"},{"key":"2022061622291586200_B19","doi-asserted-by":"crossref","unstructured":"Purow BW, Haque RM, Noel MW, et al. Expression of Notch-1 and its ligands, \u0394-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res\u20082005; 65: 2353\u201363.","DOI":"10.1158\/0008-5472.CAN-04-1890"},{"key":"2022061622291586200_B20","doi-asserted-by":"crossref","unstructured":"Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell\u20082002; 108: 153\u20134.","DOI":"10.1016\/S0092-8674(02)00625-6"},{"key":"2022061622291586200_B21","doi-asserted-by":"crossref","unstructured":"Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM. Binding and modulation of p53 by p300\/CBP coactivators. Nature\u20081997; 387: 823\u20137.","DOI":"10.1038\/42981"},{"key":"2022061622291586200_B22","doi-asserted-by":"crossref","unstructured":"Oswald F, Tauber B, Dobner T, et al. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol\u20082001; 21: 7761\u20134.","DOI":"10.1128\/MCB.21.22.7761-7774.2001"},{"key":"2022061622291586200_B23","doi-asserted-by":"crossref","unstructured":"Wendel HG, De Stanchina E, Fridman JS, et al. Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature\u20082004; 428: 332\u20137.","DOI":"10.1038\/nature02369"},{"key":"2022061622291586200_B24","doi-asserted-by":"crossref","unstructured":"Polunovsky VA, Gingras AC, Sonenberg N, et al. Translational control of the antiapoptotic function of Ras. J Biol Chem\u20082000; 275: 24776\u201380.","DOI":"10.1074\/jbc.M001938200"},{"key":"2022061622291586200_B25","unstructured":"Hershey JWB, Miyamoto S. Translational control of gene expression. In: Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor; 2000. p. 637\u201354."},{"key":"2022061622291586200_B26","doi-asserted-by":"crossref","unstructured":"Imatani A, Callahan R. Identification of a novel Notch4\/int-3 RNA species encoding an activated gene product in certain human tumor cell lines. Oncogene\u20082000; 2: 223\u201331.","DOI":"10.1038\/sj.onc.1203295"},{"key":"2022061622291586200_B27","doi-asserted-by":"crossref","unstructured":"Siziopikou K, Jang MS, Miao H, Miele L. Notch signaling in ductal carcinoma in situ of the breast. Proc Am Assoc Cancer Res\u20082002; 43: 4.","DOI":"10.1186\/bcr482"},{"key":"2022061622291586200_B28","doi-asserted-by":"crossref","unstructured":"Weijzen S, Rizzo P, Braid M, et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med\u20082002; 8: 979\u201386.","DOI":"10.1038\/nm754"},{"key":"2022061622291586200_B29","unstructured":"Koller E, Shepard PJ, Dean NM. An antisense oligonucleotide inhibitor of Jagged2 causes apoptosis in breast cancer cells. Proc Am Assoc Cancer Res\u20082002; 43: 89."},{"key":"2022061622291586200_B30","doi-asserted-by":"crossref","unstructured":"Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science\u20082004; 306: 269\u201371.","DOI":"10.1126\/science.1102160"},{"key":"2022061622291586200_B31","doi-asserted-by":"crossref","unstructured":"Shelly LL, Fuchs C, Miele L. Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem\u20081999; 73: 164\u20135.","DOI":"10.1002\/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0"},{"key":"2022061622291586200_B32","doi-asserted-by":"crossref","unstructured":"MacKenzie F, Duriez P, Wong F, Noseda M, Karsan A. Notch4 inhibits endothelial apoptosis via RBP-J\u03ba-dependent and-independent pathways. J Biol Chem\u20082004; 279: 11657\u20133.","DOI":"10.1074\/jbc.M312102200"},{"key":"2022061622291586200_B33","doi-asserted-by":"crossref","unstructured":"Martinez Arias A, Zecchini V, Brennan K. CSL-independent Notch signalling: a check point in cell fate decisions during development? Curr Opin Genet Dev\u20082002; 12: 524\u201333.","DOI":"10.1016\/S0959-437X(02)00336-2"},{"key":"2022061622291586200_B34","doi-asserted-by":"crossref","unstructured":"Ordentlich P, Lin A, Shen CP, et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol\u20081998; 18: 2230\u20139.","DOI":"10.1128\/MCB.18.4.2230"},{"key":"2022061622291586200_B35","doi-asserted-by":"crossref","unstructured":"Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell\u20082000; 103: 253\u201362.","DOI":"10.1016\/S0092-8674(00)00117-3"},{"key":"2022061622291586200_B36","doi-asserted-by":"crossref","unstructured":"Beuvink I, Boulay A, Fumagalli S, et al. The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation. Cell\u20082005; 120: 747\u20139.","DOI":"10.1016\/j.cell.2004.12.040"},{"key":"2022061622291586200_B37","doi-asserted-by":"crossref","unstructured":"Grolleau A, Bowman J, Pradet-Balade B, et al. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J Biol Chem\u20082002; 277: 22175\u201384.","DOI":"10.1074\/jbc.M202014200"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/9\/4715\/2567323\/4715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/9\/4715\/2567323\/4715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:37:49Z","timestamp":1683434269000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/9\/4715\/532875\/Survival-Signaling-by-Notch1-Mammalian-Target-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2006,5,1]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-3830","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494948.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494948","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22366010.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366010","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}